ERIKA NATHAN: Open Payments
NPI 1174675516 · WILLOUGHBY HILLS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$720 in 34 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $811 · 2025 $720
Food & beverage: $720
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 11 | $236 |
| ABBVIE INC. | 6 | $145 |
| Otsuka America Pharmaceutical, Inc. | 4 | $85 |
| Lundbeck LLC | 5 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $56 |
| Axsome Therapeutics, Inc. | 2 | $46 |
| Collegium Pharmaceutical, Inc. | 2 | $31 |
| Corium, LLC | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: INGREZZA, REXULTI, VRAYLAR, TRINTELLIX, Sunosi, Jornay PM, Azstarys, CAPLYTA.
Industry payments across OH — which companies pay providers there.
